1,271
Participants
Start Date
September 7, 2022
Primary Completion Date
June 5, 2023
Study Completion Date
May 7, 2024
V181 High-Potency Level
0.5 mL SC dose of V181 High-Potency vaccine
V181 Mid-Potency Level
0.5 mL SC dose of V181 Mid-Potency vaccine
V181 Low-Potency Level
0.5 mL SC dose of V181 Low-Potency vaccine
Placebo
0.5 mL SC dose of placebo
Kaohsiung Medical University Hospital-Infectious diseases Division, Department of Internal Medicine, Kaohsiung City
Emeritus Research ( Site 0010), Botany
Paratus Clinical Research Western Sydney ( Site 0007), Blacktown
Emeritus Research ( Site 0009), Camberwell
USC Clinical Trials Brisbane (South Bank) ( Site 0006), South Brisbane
USC Clinical Trials Moreton Bay ( Site 0001), Morayfield
USC Clinical Trials Sunshine Coast ( Site 0005), Sippy Downs
Berliner Centrum für Reise- und Tropenmedizin ( Site 0043), Berlin
Rochester Clinical Research, Inc. ( Site 0122), Rochester
Bernhard Nocht Institute for Tropical Medicine ( Site 0041), Hamburg
FVR, Turun rokotetutkimusklinikka ( Site 0031), Turku
Alliance for Multispecialty Research LLC (AMR - Norfolk) ( Site 0123), Norfolk
FVR, Porin rokotetutkimusklinikka ( Site 0033), Pori
FVR, Tampereen rokotetutkimusklinikka ( Site 0039), Tampere
Advanced Medical Research Institute ( Site 0115), Miami
FVR, Seinäjoen rokotetutkimusklinikka ( Site 0040), Seinäjoki
FVR, Kokkolan rokotetutkimusklinikka ( Site 0037), Kokkola
University of Texas Medical Branch ( Site 0113), Galveston
IMA Clinical Research San Antonio ( Site 0111), San Antonio
Klinikum der Ludwig-Maximilians-Universitaet Muenchen-Division of Infectious Diseases and Tropical (, München
FVR, Oulun rokotetutkimusklinikka ( Site 0032), Oulu
California Research Foundation ( Site 0114), San Diego
Rambam Health Care Campus-Oncology ( Site 0053), Haifa
Sheba Medical Center-Early Phase Clinical Trials Unit ( Site 0051), Ramat Gan
Hadassah Medical Center-Clinical Reaserch Unit ( Site 0052), Jerusalem
Diex Recherche Quebec Inc. ( Site 0022), Québec
Diex Recherche Joliette ( Site 0023), Saint-Charles-Borromée
Diex Recherche Sherbrooke Inc. ( Site 0024), Sherbrooke
Diex Recherche Victoriavile Inc. ( Site 0021), Victoriaville
FVR, Espoon rokotetutkimusklinikka ( Site 0036), Espoo
FVR, Etelä-Helsingin rokotetutkimusklinikka ( Site 0038), Helsinki
FVR, Itä-Helsingin rokotetutkimusklinikka ( Site 0035), Helsinki
Merck Sharp & Dohme LLC
INDUSTRY